|
|
|
|
|
| First Name: | Breno | | Last Name: | Diniz | | Title: | M.D. | | Affiliation: | Faculty of Medicine, University of São Paulo | | Department: | Laboratory of Neuroscience, Dept. of Psychiatry | | Street Address 1: | Rua dr. Ovidio Pires de Cmapos, 785, 3th floor | | City: | São Paulo | | State/Province: | SP | | Zip/Postal Code: | 05403-010 | Country/Territory: | Brazil | | Phone: | +55 11 3069-7267 | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports no financial or other potential conflicts of interest. [Last Modified: 8 January 2011]
|
|
|
View all comments by Breno Diniz
|
Aging Process, Alzheimer Disease
|
Neurobiology, Neuroimmunology, Oxidative Stress, Diagnosis, Biomarkers
|
Medical graduation at the Federal University of Minas Gerais, Brazil.
Residency training in Psychiatry at the Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brasil.
MD and PhD degrees at the the Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Brasil. |
1: Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease. J Alzheimers Dis. 2010 Jan 1;22(4):1305-11. PubMed PMID: 20930310.
2: Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Izzo G, Gattaz WF. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol
Psychiatry. 2010 Sep;11(6):774-80. PubMed PMID: 20491609.
3: Forlenza OV, Diniz BS, Talib LL, Radanovic M, Yassuda MS, Ojopi EB, Gattaz WF. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Rev Bras Psiquiatr. 2010 Sep;32(3):216-22.PubMed PMID: 20414590.
4: Diniz BS, Nunes PV, Yassuda MS, Forlenza OV. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord. 2009;27(3):224-31. PubMed PMID: 19225236.
5: Diniz BS, Pinto JA Jr, Gonzaga ML, Guimar√£es FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2009 Jun;259(4):248-56. PubMed PMID: 19224111.
6: Diniz BS, Pinto J√∫nior JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry. 2008;9(3):172-82. PubMed PMID: 17886169.
7: Diniz BS, Yassuda MS, Nunes PV, Radanovic M, Forlenza OV. Mini-mental State Examination performance in mild cognitive impairment subtypes. Int Psychogeriatr. 2007 Aug;19(4):647-56. PubMed PMID: 17502007.
8: Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, Radanovic M, Abreu ID, Borelli DT, Gattaz WF, Forlenza OV. Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr. 2008 Dec;30(4):316-21. PubMed PMID: 19142405. |
The patterns of interaction between distinct potential physiopathological mechanisms related to Alzheimer's disease in the ageing and neurodegenerative processes. |
O'Bryant et al. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol (2010) vol. 67 (9) pp. 1077-81.
De Meyer et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol (2010) vol. 67 (8) pp. 949-56 |
|
|
|
|
|
|
Home
